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Sunday, February 3, 2013 153aPatients in heart failure are sometimes implanted with a left ventricular assist
device (LVAD) to bridge them to transplant. Clinical data shows that ~15%
of these patients recover pump function and can subsequently have their
LVAD removed. The goal of our study was to determine whether cellular level
maximal power output of the left ventricle improves after patients are fitted
with LVADs. Myocardial samples were obtained (1) from the left ventricle
apex of patients when they were implanted with a LVAD and (2) from the
left ventricle free wall when they subsequently received a heart transplant.
Non failing cardiac samples were also obtained from organ donors for compar-
ison. All samples were snap frozen in liquid nitrogen and stored in the vapor
phase of liquid nitrogen. Multicellular preparations were then obtained by
chemically permeabilizing the samples in 1% Triton solution after mechanical
homogenization. These preparations were connected between a force trans-
ducer and a motor and maximally activated in a saturating Ca2þ solution.
Once force had reached steady state, the preparations were allowed to shorten
against pre-set loads imposed using SLControl software. Maximum power out-
put was determined from the force-velocity curves. Preliminary results suggest
that LVAD treatment improved cellular level maximum power output and
isometric force. There was also a trend towards a lower maximum shortening
velocity post-LVAD. Further studies, will determine whether intrinsic ventric-
ular function is improved by LVAD implantation as well as the molecular
mechanisms that may mediate any observed responses.
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Omecamtiv mecarbil (OM), a small-molecule increases cardiac contractility by
directly activating cardiac myosin by accelerating phosphate (Pi) release (Ma-
lik et al., 2011). Here we analyzed the affect of OM on the mechanochemical
cycle and motility of human b-cardiac heavymeromyosin expressed in a adeno-
viral/C2C12 muscle cell based system, and purified porcine ventricular myosin
(PV-HMM). Double-mixing stopped-flow fluorescence and phosphate binding
protein (MDCC-PBP) were used to determine the maximum rate (kmax) of
phosphate release. Rates of 30s1 and 35s1 were obtained for human and
porcine cardiac HMM respectively. Addition of 20 mM OM resulted in a
2-fold increase in the maximal rate of actin activated Pi release to kmax =
70 s1 (AM-ADP-Pi _> AM-ADP þ Pi) for both human and porcine cardiac
HMM. The unloaded actin filament velocity measured in the in vitro motility
assay was 0.76 5 0.37 mm/sec for human b-cardiac HMM and 0.97 5 0.23
mm/sec for PV-HMM. OM has two effects on the motor activity: 1) The actin
filament velocity was significantly slower (~ 16 -fold at saturation); 2) the fil-
ament motion became more persistent with long periods of uninterrupted
movement. This suggests that OM recruits more crossbridges to participate
in the movement of the actin filaments resulting in higher forces per filament,
which overcomes the pinning defects that invariably trap actin filaments in nor-
mal motility assays. The increase in attached crossbridges/filament also slows
the filament velocity. The motility data are consistent with the kinetic analysis
indicating that OM accelerates Pi release without dramatically enhancing the
rate of the ATPase hydrolysis. This produces a higher duty ratio in which the
motor spends more of the ATPase cycle in tight binding states. Supported by
AHA-BGIA to EF and AHA-GI to DAW.
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After myocardial infarction, adjacent to the infarct there is a poorly contracting
non-ischemic border zone. The mechanism of border zone dysfunction is un-
clear. We found that border zone dysfunction does not involve myocardial
fibrosis, or a decreased content of either myofibrils or myosin, suggesting there
is a defect in the contractile mechanism. Goal: Determine the mechanism for
border zone dysfunction. Methods: We used sheep hearts 2 weeks after
apical infarction. Cardiac muscle strips were dissected from the border zone
adjacent to the infarct and from a zone remote from the infarct. Myofilament
contraction was assessed using in-vitro isometric and isotonic contractions of
demembranated cardiac muscle strips bathed in activating solutions. To assess
strongly bound cross-bridge formation, we measured muscle stiffness using
high frequency, low amplitude oscillations of muscle length in the absenceof ATP (in this rigor state, cross bridge formation should be maximal).
Results: In border zone myocardium, maximal force development (Fmax)
was reduced by 3152% (n=6, P<0.01) compared to Fmax of remote zone
myocardium (8551 mN/mm2). The stiffness in the rigor state was reduced
by 3456% (n=5, P<0.05) in border zone myocardium versus remote zone
myocardium, suggesting impaired cross bridge formation in the border zone.
There was no difference between border zone and remote zone myocardium
in the maximum velocity of muscle shortening (~0.35 muscle lengths/s),
or in the rate constant of force redevelopment (Ktr, ~2.5 s1) after briefly
mechanically disrupting cross bridges with a rapid perturbation of muscle
length. Conclusions: Impaired contraction of border zone myocardium
involves a reduction in cross bridge formation, without effects on cross bridge
kinetics. Preliminary studies suggest proteolytic cleavage of contractile pro-
teins may play a role.
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Heart failure is characterized by a decrease in cardiac contractility and is a lead-
ing cause of morbidity and mortality. Treatment with cardiac glycosides such
as digitalis increases cardiac contractility by elevating intracellular calcium
through inhibition of the sodium-potassium ATPase (NKA). However, the ther-
apeutic window for this class of drugs is narrow as high calcium levels lead to
increased SR load, calcium leak, and cardiac arrhythmias. Alternatively, the
endogenous inhibitor of NKA, phospholemman (PLM), is dynamically regu-
lated. We hypothesize that a superinhibitory mutant of PLM will increase the
contractility of cardiac myocytes. This effect will be inherently self-limiting
since inhibition of NKA is relieved by phosphorylation or elevated intracellular
sodium. Here we used a high-throughput screen of PLM mutants utilizing fluo-
rescence microscopy to simultaneously measure PLM-NKA and PLM-PLM
binding. By tagging NKA with CFP and PLM with YFP, we can measure
NKA-PLM binding with heterotransfer FRET (CFP to YFP) and oligomeriza-
tion of PLM with homotransfer FRET (YFP to YFP). We observed that several
mutants have a decreased affinity for oligomerization (PLM-PLM binding)
leading to an increased apparent affinity for NKA. Future plans include creating
and screening many more mutants and measuring the functional effect of PLM-
based superinhibitors in vitro and in vivo.
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Ventricular fibrillation is one of the leading causes of death in the world.
Current therapy is based on a high-energy electric shock, which indiscrimin-
ately excites every cell in the muscle and may cause severe side effects such
as tissue damage and intolerable pain. The complex spatio-temporal dynamics
of fibrillation, induced by multiple interacting spiral waves, makes the design of
robust low-energy control strategies a challenging scientific problem.
Low-energy electric field stimuli lead to the formation of wave emitting sites at
structural heterogeneities in the tissue, with a density adjustable through field
strength. By applying a sequence of electric-field pulses, Low-Energy Anti-
Fibrillation pacing (LEAP) uses these wave sources to non-invasively control
the tissue from multiple sites and terminate fibrillation by progressive synchro-
nization. We present experiments on canine dogs, investigating the application of
LEAP to atrial (in-vitro and in-vivo) and ventricular fibrillation (in-vitro) as well
as the wave source recruitment mechanism in quiescent tissue [1]. We show that
the observed wave source density is in agreement with theoretical predictions
based on the size distribution of the cardiovascular tree. These findings are sup-
ported and extended by theoretical investigations revealing a general curvature-
dependent sensitivity of anatomical features to electric-field stimulation [2].
LEAP results in an energy reduction of 80% for the termination of fibrillation
compared to conventional defibrillation. Further energy reduction might be pos-
sible in specific scenarios by making use of negative-curvature structures on the
endocardium such as trabecular, papillary and pectinate muscles.
References:
[1] S. Luther*, F.H. Fenton* et al., Low-energy control of electrical turbulence
in the heart, Nature 475, 235-239 (2011).
154a Sunday, February 3, 2013[2] P. Bittihn, M. Ho¨rning, and S. Luther, Negative curvature boundaries as
wave emitting sites for the control of biological excitable media, Phys. Rev.
Lett. 109, 118106 (2012).
* Both authors have contributed equally.
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Laser irradiation has developed into a novel technique of non-invasive stimu-
lation in cardiac and neural tissues. However, physical parameters for the laser
irradiation-induced cardiac contractions have not been clarified, because vari-
ous physicochemical reactions, such as photochemical and photothermal
effects, are triggered in this process. Here we studied the effects of laser-
induced local temperature changes on the functions of isolated cardiomyocytes.
We demonstrated previously that a microscopic heat pulse (DT = 0.2C for
2 sec) induces a Ca2þ burst in cancer cells (HeLa cells) at a body temperature
(Tseeb et al., HFSP J., 2009), with the mechanism similar to that of rapid cool-
ing contracture in skeletal and cardiac muscles. In the present study, we gener-
ated microscopic heat pulses by focusing infrared laser light in extracellular
solution near adult rat cardiomyocytes. We found that a microscopic heat pulse
(DT = 5C for 0.5 sec) induces contractions at basal temperature of 36C. At
25C, larger DT was required to induce contractions. When 2.5 Hz heat pulses
were repeatedly applied, we observed oscillatory contractions of cardiomyo-
cytes. Different from contractions induced by electric stimulation, Ca2þ tran-
sients were not detected during the contraction. Likewise, heat pulses
induced contractions of skinned cardiomyocytes in Ca2þ-free solution in the
presence of ATP. These results demonstrate that heat pulses can regulate
cardiac contractions without any involvement of Ca2þ dynamics, by directly
activating the actomyosin interaction. Hence, our microheating technique
may be useful for stimulating the beating of failing hearts without causing
abnormal Ca2þ dynamics.
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Ischemic heart disease is a leading cause of morbidity and mortality in the
world. To help gain insight into mechanisms and forge new experimental ther-
apeutics we are using time-resolved fluorescence resonance energy transfer
(TR-FRET) to detect structural changes within the cardiac troponin complex
that occur during acute ischemic insult. During an ischemic event, penultimate
to cell death, the sarcomere undergoes acidification. In cardiac myocytes, this
decrease in pH uncouples calcium homeostasis from contractility. We have
shown that the neonatal cardiac isoform of TnI, ssTnI, exhibits reduced pH-
sensitivity compared to the adult cTnI isoform, however ssTnI confers delete-
rious effects at baseline in the context of an adult myocyte. Functional studies
demonstrated that this pH-insensitivity stems from ssTnI residue H132. Intro-
duction of a histidine at the homologous position in cTnI (A164H) mitigates the
pH-sensitivity of the calcium-force relationship in cardiac myocytes. We are
now establishing a TR-FRET approach to detect structural changes within
the troponin complex in functional thin filaments with the goal of elucidating
the structural dynamics that control pH-sensitive calcium-activated force pro-
duction in the heart. We have engineered labeling sites designed to detect
Ca2þ and pH sensitive structural changes in cTnI and cTnC. We will discuss
our progress on utilizing a novel high-throughput fluorescence lifetime plate-
reader that allows high-precision detection of time-resolved fluorescence.
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An autoimmune related inflammation occurring after group A streptococcal in-
fection is believed to be behind the development of rheumatic heart disease.
The group A streptococcal conservative M protein sequence when injected
into mice generates a promiscuous antibody referred to as mAb10F5. Injection
of the M protein sequence into Lewis rats results in heart manifestations andinjection of mAb10F5 which is against M protein sequence into Lewis rats re-
sults in the display of the antibody in the heart, especially in the valve region.
The binding of mAb10F5 in the heart resembles that of anti-cardiac myosin
with binding in all three regions of the heart examined (artial, valve and
ventricular apex) during the first 72 hrs after injection. However, mAb10F5 re-
mains significantly bound in the valve region at 72 hrs while binding of anti-
cardiac myosin binding decreases. MAb10F5 is an IgG2b antibody and mouse
IgG2b has been shown to promote autoimmunity in the mouse. However, injec-
tion of just mouse IgG2b into Lewis rats leads to little binding of antibody in
the heart. The binding that does occur is again greatest in the valve region,
but dissipates after the first 24 hrs and is virtually negative by 72 hrs. This is
significantly different from mAb10F5 which remains significantly bound in
this region at the 72 hr time point (p = 7.95E-16, ANOVA). Thus, though
IgG2b may have initial autoreactivity in the first 24 hrs, it does not remain
bound in the heart valve region. Therefore, mAb10F5 which is associated
with the streptococcal conservative M protein sequence demonstrates a more
specific reactivity to this region of the heart which may be a factor in the de-
velopment of valvulitis.
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We seek to understand the energetics and design principle of the TnTmA7
switch and the basis for cooperative activation. Single molecule studies provide
the needed resolution, revealing conformational substates in a model-
independent manner. Multiple single-cysteine mutants of cardiac TnI (cTnI)
and cardiac TnC (cTnC) were engineered to generate an assay to resolve
Ca2þ- and myosin-dependent conformational substates of cTn in single mole-
cule FRET experiments. Thin filaments were reconstituted from F-actin, Tm,
and cTn, which consisted of donor (AlexaFluor 546)-labeled cTnI, acceptor
(ATTO655)-labled cTnC, and wt cTnT. Optimized buffer conditions provide
stably associated thin filaments at a 1 nM concentration. Complex stability
was confirmed by fluorescence cross-correlation spectroscopy (FCCS). In the
most promising cTn construct, Ca2þ saturation increases the TE by 14%.
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Protein kinase A (PKA) phosphorylation of myofibrillar proteins constitutes an
important pathway for beta-adrenergic modulation of cardiac contractility and
relaxation. PKA targets the N-terminus of cardiac troponin I (cTnI), cardiac
myosin-binding protein C (cMyBP-C) and titin. We recently reported that
PKA phosphorylation of cTnI alone, or in combination with cMyBP-C, is suf-
ficient to suppress cardiac contractility and the sarcomere length dependence of
contraction. Troponin C (cTnC) interaction with cTnI (C-I) is a critical step in
contractile activation that may be modulated by cTnI phosphorylation. Here we
tested the hypothesis that altering C-I interactions by PKA, or by phosphomi-
metic mutations in cTnI, directly affects myofilament relaxation. Using a fluo-
rescent probe coupled to cTnC (C35S IANBD), the Ca2þ binding affinity to
troponin complex (cTn) and C-I interaction affinity were monitored. Ca2þ bind-
ing to cTn (pCa50) was significantly decreased by PKA, when both whole cTn
or cTnI alone were phosphorylated (pCa50 = 0.3 and 0.1 units, respectively).
PKA phosphorylation of cTnI also weakened C-I interaction in the presence
or absence of Ca2þ, with a greater effect for the former. Rat ventricular myo-
fibrils were isolated and endogenous cTn was exchanged with either wild type
(WT), nonphosphorylatable (S23/24A cTnI) or phosphomimetic (S23/24D
cTnI) recombinant cTn. Mechanics were monitored at maximum and submax-
imal Ca2þ. PKA treatment of WT or S23/24D cTnI exchange resulted in a sig-
nificantly increased slow phase relaxation rate (kREL,slow) and decreased
duration of slow phase relaxation (tREL,slow). These effects were largest at sub-
maximal Ca2þ. In contrast, exchange with S23/24A cTnI resulted in no effects
on relaxation kinetics. Together these data suggest that weakened C-I interac-
tion affinity from PKA phosphorylation results in increased myofilament relax-
ation kinetics. These effects may enhance early phase diastolic relaxation
during beta-adrenergic stimulation. Supported by AHA7400069 (VR),
AHA2090056 (DW), HL65497 (MR).
792-Pos Board B561
N-Terminal Truncated Cardiac Troponin I Enhanced the Contractility of
Isolated Cardiomyocytes
Hongguang Wei, J.-P. Jin.
Wayne State University school of medicine, Detroit, MI, USA.
Cardiac TnI has a unique N-terminal extension that is a heart-specific regula-
tory structure not present in skeletal muscle TnI. Previous studies have
